Homocysteine-Lowering Therapy and Early Progression of Transplant Vasculopathy: A Prospective, Randomized, IVUS-Based Study-Reference-Cited by-同舟云学术

Homocysteine-Lowering Therapy and Early Progression of Transplant Vasculopathy: A Prospective, Randomized, IVUS-Based Study

Published:2005-09 Issue:9 Volume:5 Page:2258-2264
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Potena Luciano,Grigioni Francesco,Magnani Gaia,Ortolani Paolo,Coccolo Fabio,Sassi Simonetta,Koessels Koen,Marrozzini Cinzia,Marzocchi Antonio,Carigi Samuela,Musuraca Anna C.,Russo Antonio,Magelli Carlo,Branzi Angelo

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2005.01015.x/fullpdf

Reference44 articles.

1. The registry of the international society for heart and lung transplantation: twentieth official adult heart transplant report—2003

2. Cardiac Allograft Vasculopathy

3. Cardiac Allograft Vasculopathy and Dysregulation of the NO Synthase Pathway

4. Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy;Progress in Cardiovascular Diseases;2020-05

2. Vitamin therapy after heart transplantation;Expert Review of Cardiovascular Therapy;2015-09-12

3. Pediatric Coronary Allograft Vasculopathy-A Review of Pathogenesis and Risk Factors;Congenital Heart Disease;2011-12-18

4. Homocysteine and P wave dispersion in patients with heart transplantation;Clinical Transplantation;2011-01

5. Everolimus: efficacy and safety in cardiac transplantation;Expert Opinion on Drug Safety;2010-08-12